[go: up one dir, main page]

DK0435362T3 - Præparat med et indhold af et ikke-steroidt, anti-inflammatorisk middel og et ikke-baktericidt virksomt tetracyclin - Google Patents

Præparat med et indhold af et ikke-steroidt, anti-inflammatorisk middel og et ikke-baktericidt virksomt tetracyclin

Info

Publication number
DK0435362T3
DK0435362T3 DK90203190.5T DK90203190T DK0435362T3 DK 0435362 T3 DK0435362 T3 DK 0435362T3 DK 90203190 T DK90203190 T DK 90203190T DK 0435362 T3 DK0435362 T3 DK 0435362T3
Authority
DK
Denmark
Prior art keywords
tetracycline
inflammatory agent
steroidal
bactericidal
amount
Prior art date
Application number
DK90203190.5T
Other languages
Danish (da)
English (en)
Inventor
Lorne M Golub
Thomas F Mcnamara
Nangavarum S Ramamurthy
Robert A Greenwald
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of DK0435362T3 publication Critical patent/DK0435362T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90203190.5T 1989-12-04 1990-12-03 Præparat med et indhold af et ikke-steroidt, anti-inflammatorisk middel og et ikke-baktericidt virksomt tetracyclin DK0435362T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44541089A 1989-12-04 1989-12-04

Publications (1)

Publication Number Publication Date
DK0435362T3 true DK0435362T3 (da) 1993-05-24

Family

ID=23768789

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90203190.5T DK0435362T3 (da) 1989-12-04 1990-12-03 Præparat med et indhold af et ikke-steroidt, anti-inflammatorisk middel og et ikke-baktericidt virksomt tetracyclin

Country Status (8)

Country Link
US (2) US5321017A (fr)
EP (1) EP0435362B1 (fr)
JP (1) JP3016587B2 (fr)
AT (1) ATE88346T1 (fr)
CA (1) CA2031368C (fr)
DE (1) DE69001429T2 (fr)
DK (1) DK0435362T3 (fr)
ES (1) ES2055309T3 (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308839A (en) * 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
US5523297A (en) * 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5668122A (en) * 1993-07-28 1997-09-16 Fife; Rose S. Method to treat cancer with tetracyclines
EP0736302A3 (fr) * 1995-03-23 1997-06-04 Stichting Rega V Z W Inhibiteurs de protéases, construction d'ADN pour l'expression d'une protéase et un procédé pour mesurer les protéases et/ou les inhibiteurs de protéases
EP0733369A1 (fr) * 1995-03-23 1996-09-25 Stichting REGA V.Z.W. Inhibiteurs de protéases, construction d'ADN pour l'expression d'une protéase et procédé pour mesurer les protéases et/ou les inhibiteurs de protéases
GB9608133D0 (en) * 1996-04-19 1996-06-26 Gemini International Holdings Diagnostic method and apparatus
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5837696A (en) * 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US6429204B1 (en) 1997-01-15 2002-08-06 University Of Miami Method of inhibiting cancer growth
US5773430A (en) * 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
GB9714936D0 (en) * 1997-07-17 1997-09-17 Smith & Nephew Cell culture products
PT1041991E (pt) * 1997-12-19 2008-10-03 Univ New York Tetraciclinas não antibacterianas para o tratamento de esclerose múltipla
PT102160B (pt) * 1998-05-26 2001-04-30 Hovione Sociedade Quimica S A Processo para a preparacao de 4-(des-dimetilamino)-tetraciclinas
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
US6946453B2 (en) 1998-11-18 2005-09-20 Collagenex Pharmaceuticals, Inc. 4-dedimethylaminotracycline derivatives
US9616150B2 (en) * 1999-10-29 2017-04-11 Children's Hospital Los Angeles Bone hemostasis method and materials
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
WO2002083106A1 (fr) * 2001-04-05 2002-10-24 Collagenex Pharmaceuticals, Inc. Delivrance controlee de composes de tetracycline et de derives de tetracycline
EP2301915A1 (fr) 2001-07-13 2011-03-30 Paratek Pharmaceuticals, Inc. Tétracycline avec groupe 7-(diethylamino)methyl doté d'activités thérapeutiques
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
AU2002357370A1 (en) * 2001-12-20 2003-07-09 Hartmut M. Hanauske-Abel Treatment for averting or delaying premature delivery
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
EP2311797A1 (fr) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. Composés de tétracycline 4-dedimethylamino
IL163931A0 (en) 2002-03-08 2005-12-18 Paratek Pharm Innc Amino-methyl substituted tetracyline compounds
CN1653037A (zh) 2002-03-21 2005-08-10 帕拉特克药品公司 取代的四环素化合物
DE10227938B4 (de) * 2002-06-21 2006-07-20 Heraeus Kulzer Gmbh Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung
WO2004006850A2 (fr) 2002-07-12 2004-01-22 Paratek Pharmaceuticals, Inc Composes de tetracycline substituee en 3, 10, et 12a
DK2204168T3 (en) * 2003-04-07 2015-04-07 Supernus Pharmaceuticals Inc Tetracycline for administration once a day
KR101228706B1 (ko) 2003-07-09 2013-02-01 파라테크 파마슈티컬스, 인크. 치환된 테트라시클린 화합물
WO2005009944A1 (fr) 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Promedicaments de composes de la tetracycline substitues par 9-aminomethyle
US7786099B2 (en) * 2004-01-15 2010-08-31 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
US7189456B2 (en) * 2004-03-04 2007-03-13 Transitions Optical, Inc. Photochromic optical article
US20060063745A1 (en) * 2004-09-22 2006-03-23 Charles Berman Composition for relieving pain and improving mobility
EP2284164A3 (fr) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Composés de tétracycline substituée
AU2005299294B2 (en) 2004-10-25 2012-06-07 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
US20080207673A1 (en) * 2005-05-04 2008-08-28 Michel Xilinas Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
AU2006272698B2 (en) * 2005-07-21 2012-11-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
BRPI0602372B8 (pt) 2006-05-18 2021-06-22 Einco Biomaterial Ltda processo de preparação de compósitos em base de biocerâmicas e polímeros biodegradáveis e produto derivado
WO2008079339A2 (fr) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Composés de tétracycline substituée
DK2120963T3 (en) * 2006-12-21 2019-01-14 Paratek Pharm Innc SUBSTITUTED TETRACYCLINE COMPOUNDS FOR TREATMENT OF INFLAMMATORY SKIN DISORDERS
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
AU2008246119A1 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
BRPI0813990A2 (pt) * 2007-07-06 2011-09-13 Paratek Pharm Innc métodos para sintetizar compostos de minociclina substituìda
TW202332671A (zh) * 2008-05-19 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2010017310A1 (fr) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Procédé pour le traitement de l'acné, et certaines formes posologiques de celui-ci
PL2323972T3 (pl) 2008-08-08 2014-01-31 Tetraphase Pharmaceuticals Inc C7-fluoro podstawione związki tetracyklinowe
BRPI0918050A2 (pt) * 2008-09-19 2015-09-22 Paratek Pharm Innc compostos de tetraciclina para o tratamento de artrite reumatoide e metodos relacionados de tratamento
CA2761241C (fr) 2009-05-08 2018-02-27 Tetraphase Pharmaceuticals, Inc. Composes de tetracycline
CA2772386C (fr) 2009-08-28 2017-09-19 Tetraphase Pharmaceuticals, Inc. Composes tetracycline
NZ603323A (en) 2010-03-31 2014-12-24 Tetraphase Pharmaceuticals Inc Polycyclic tetracycline compounds
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
MX390763B (es) 2012-08-31 2025-03-21 Tetraphase Pharmaceuticals Inc Compuestos de tetraciclina
CN109661465A (zh) 2016-07-21 2019-04-19 诺维信公司 丝氨酸蛋白酶变体以及对其进行编码的多核苷酸
CN109642225A (zh) 2016-07-21 2019-04-16 诺维信公司 丝氨酸蛋白酶变体以及对其进行编码的多核苷酸
SG11201903327PA (en) 2016-10-19 2019-05-30 Tetraphase Pharmaceuticals Inc Crystalline forms of eravacycline
WO2020097450A1 (fr) 2018-11-09 2020-05-14 Tetraphase Pharmaceuticals, Inc. Formes polymorphes d'un composé et utilisations associées

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3304227A (en) * 1965-07-15 1967-02-14 Loyal E Loveless Antibiotic-containing animal feed
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US4049700A (en) * 1976-06-17 1977-09-20 The Upjohn Company Ibuprofen p-hydroxyphenylurea ester
US4189497A (en) * 1977-11-22 1980-02-19 American Cyanamid Company Method of treating arthritic disease
US4269832A (en) * 1978-04-12 1981-05-26 American Cyanamid Company Method of treating arthritic disease
US4218449A (en) * 1978-08-21 1980-08-19 John R. A. Simoons Treatment of rheumatoid arthritis and related diseases
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4935412A (en) * 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
US5045538A (en) * 1990-06-28 1991-09-03 The Research Foundation Of State University Of New York Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines

Also Published As

Publication number Publication date
ES2055309T3 (es) 1994-08-16
US5459135A (en) 1995-10-17
JPH03227931A (ja) 1991-10-08
CA2031368A1 (fr) 1991-06-05
EP0435362A1 (fr) 1991-07-03
ATE88346T1 (de) 1993-05-15
CA2031368C (fr) 2002-01-29
EP0435362B1 (fr) 1993-04-21
JP3016587B2 (ja) 2000-03-06
US5321017A (en) 1994-06-14
DE69001429D1 (de) 1993-05-27
DE69001429T2 (de) 1993-07-29

Similar Documents

Publication Publication Date Title
DK0435362T3 (da) Præparat med et indhold af et ikke-steroidt, anti-inflammatorisk middel og et ikke-baktericidt virksomt tetracyclin
CA2105529A1 (fr) Composition contenant un anti-inflammatoire non steroidien et une tetracycline non antibacterienne efficace
MX9204381A (es) Metodo para tratar inflamacion ocular
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
ATE39323T1 (de) Injizierbare loesung zur behandlung von entzuendungen.
ES2166110T3 (es) Agonistas no alostericos de gabaa para tratar trastornos del sueño.
ATE448797T1 (de) Zusammensetzung enthaltend il-1ra als interleukin-1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
NO943663L (no) Forbindelser som kan anvendes for behandling av allergiske sykdommer og betennelsessykdommer
FI945426L (fi) GABA- ja L-glutamiinihappoanalogit kohtauksenvastaiseen käsittelyyn
BR9812753A (pt) Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica
AU4648885A (en) Antidiarryheal compositions and use thereof
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
FI860304A7 (fi) Flupirtiinin ja ei-steroidisten anti-inflammatoristen aineiden synergistinen yhdistelmä.
DK0533213T3 (da) Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis
NO983530L (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
BR0112212A (pt) Uma combinação de inibidores de fbpase e agentes antidiabéticos úteis para o tratamento de diabetes
ATE113207T1 (de) Benzamid gegen kognitive erkrankungen.
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
DK165938C (da) Topisk middel til behandling af non-inflammatorisk acne
DK213484D0 (da) Farmaceutisk middel til behandling af slagtilfaelde og lignende krampesygdomme
NO852793L (no) (pyrrol-1-yl)-fenyldihydropyridazinoner og fremgangsmaate ved fremstilling derav.
IT8323601A0 (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete.
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
ATE269714T1 (de) Tcf-ii für vorbeugung und/oder behandlung von strahlungsinduzierter störungen
ES1022064Y (es) "dispositivo perfeccionado para la reduccion y tratamiento de fracturas trocantereas del femur y otras aplicaciones.